Claudio Lanfranco

Combined cisplatin, doxorubicin, and mitomycin for the treatment of advanced pleural mesothelioma

M.C. Pennucci, Andrea Ardizzoni, P. Pronzato et al. · Cancer · 1997 · 38 citations · Full text

Medicine, Oncology, Pharmacology +12

Cisplatin-vindesine-mitomycin (MVP) vs cisplatin-ifosfamide-vinorelbine (PIN) vs carboplatin-vinorelbine (CaN) in patients with advanced non-small-cell lung cancer (NSCLC): a FONICAP randomized phase II study

Editta Baldini, Carmelo Tibaldi, Andrea Ardizzoni et al. · British Journal of Cancer · 1998 · 27 citations · Full text

Medicine, Oncology, Pharmacology +14

Cardioprotective Effect of Dexrazoxane in Patients with Breast Cancer Treated with Anthracyclines in Adjuvant Setting

Franco Testore, Simona Milanese, Marco Ceste et al. · American Journal of Cardiovascular Drugs · 2008 · 24 citations

Medicine, Oncology, Pharmacology +14

Schedule specific biochemical modulation of 5-fluorouracil in advanced colorectal cancer: A randomized study

Alberto Sobrero, Alberto Zaniboni, Giovanni Luca Frassineti et al. · Annals of Oncology · 2000 · 17 citations · Full text

Medicine, Oncology, Pharmacology +9

Malignant peritoneal mesothelima in a 17-year-old boy with evidence of previous exposure to chrysotile and tremolite asbestos

A Andrion, S Bosia, L. Paoletti et al. · Human Pathology · 1994 · 12 citations

Medicine, Pathology, Toxicology +7